Clinical efficacy of naloxone plus aminophylline in the treatment of children with acute respiratory failure
10.3760/cma.j.issn.1008-6706.2016.18.028
- VernacularTitle:纳洛酮联合氨茶碱治疗小儿急性呼吸衰竭的临床疗效观察
- Author:
Lizhen WANG
;
Xinxin LONG
;
Yuna BI
- Publication Type:Journal Article
- Keywords:
Respiratory failure;
Naloxone;
Aminophylline
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(18):2825-2827,2828
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of naloxone plus aminophylline in the treatment of children with acute respiratory failure.Methods 72 patients with acute respiratory failure were randomly divided into the study group and the control group.36 cases in the study group were given naloxone plus aminophylline therapy, 36 cases of the control group received conventional therapy.And the clinical efficacy was compared.Results The total effective rate of the study group was 91.67%,which was significantly higher than 66.67% of the control group (χ2 =6.82,P <0.05).In the comparison of the effect of improving blood indicators,arterial blood pressure of the study group was (67.51 ±4.11)mmHg,which was significantly higher than (61.03 ±4.08)mmHg in the control group (t =2.64,P <0.05).The oxygen saturation of the study group was (93.55 ±8.05)%,which was significantly higher than (79.62 ±10.22)% of the control group (t =2.29,P <0.05).The arterial carbon dioxide partial pres-sure of the study group was (69.03 ±5.71)mmHg,which was also higher than (61.52 ±4.09)mmHg of the control group (t =2.22,P <0.05).The incidence rate of adverse reactions of study group was 2.78%,which was lower than 22.22% in the control group (χ2 =6.22,P <0.05).Conclusion Naloxone plus aminophy -lline used in children with acute respiratory failure obtain the desired therapeutic effect,not only can effectively improve blood indicators of children,and without significant adverse reactions,drug safety is high,it is worthy of promoting.
